Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21+0.06 (+5.22%)
Close on Nov 17, 2026Market cap $76.72MP/E –Yield –
Equillium operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Equillium's operating income for the twelve months ending Jun 30, 2026 was -$19.30M. For fiscal 2025 it was -$23.63M. The highest annual figure on record is -$8.27M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.63M | – |
| FY2024 | Dec 31, 2024 | -$8.27M | – |
| FY2023 | Dec 31, 2023 | -$14.52M | – |
| FY2022 | Dec 31, 2022 | -$62.08M | – |
| FY2021 | Dec 31, 2021 | -$37.79M | – |
| FY2020 | Dec 31, 2020 | -$29.55M | – |
| FY2019 | Dec 31, 2019 | -$26.73M | – |
| FY2018 | Dec 31, 2018 | -$8.62M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.96M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.87M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$679.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$100.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.79M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.20M | -256.7% |
| Q3 FY2023 | Sep 30, 2023 | -$3.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.11M | – |
| Q4 FY2022 | Dec 31, 2022 | $2.04M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.24M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.55M | – |
| Q1 FY2022 | Mar 31, 2022 | -$37.33M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.39M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.86M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.84M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.70M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.97M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.52M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.61M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.32M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.35M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.23M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.23M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.13M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.04M | – |
| Q3 FY2017 | Sep 30, 2017 | -$83.71K | – |
See a number that looks wrong?